Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 02 2020
Historique:
received: 27 11 2018
revised: 26 03 2019
accepted: 28 03 2019
pubmed: 6 5 2019
medline: 20 2 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Obesity has been associated with upper gastrointestinal cancers; however, there are limited prospective data on associations by subtype/subsite. Obesity can impact hormonal factors, which have been hypothesized to play a role in these cancers. We investigated anthropometric and reproductive factors in relation to esophageal and gastric cancer by subtype and subsite for 476,160 participants from the European Prospective Investigation into Cancer and Nutrition cohort. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox models. During a mean follow-up of 14 years, 220 esophageal adenocarcinomas (EA), 195 esophageal squamous cell carcinomas, 243 gastric cardia (GC) and 373 gastric noncardia (GNC) cancers were diagnosed. Body mass index (BMI) was associated with EA in men (BMI ≥30 vs. 18.5-25 kg/m

Identifiants

pubmed: 31050823
doi: 10.1002/ijc.32386
pmc: PMC6973006
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

929-942

Subventions

Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Int J Epidemiol. 2002 Jun;31(3):624-31
pubmed: 12055165
Am J Physiol Endocrinol Metab. 2001 Mar;280(3):E496-501
pubmed: 11171605
Tumour Biol. 2017 Mar;39(3):1010428317695020
pubmed: 28351315
Cancer. 2010 Mar 15;116(6):1572-81
pubmed: 20186831
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2079-89
pubmed: 19567501
Dis Esophagus. 2016 Jul;29(5):448-54
pubmed: 25809699
Int J Cancer. 2008 Apr 1;122(7):1604-10
pubmed: 18059032
Br J Cancer. 2008 Apr 8;98(7):1295-300
pubmed: 18382461
Gastric Cancer. 2014;17(3):463-8
pubmed: 24174008
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13
pubmed: 24618998
Clin Gastroenterol Hepatol. 2016 Mar;14(3):338-347.e1
pubmed: 26484704
Anticancer Res. 2001 Sep-Oct;21(5):3215-20
pubmed: 11848475
Helicobacter. 2016 Dec;21(6):575-580
pubmed: 27098759
Int J Cancer. 2015 Aug 1;137(3):646-57
pubmed: 25598323
World J Gastroenterol. 2012 Feb 7;18(5):393-400
pubmed: 22346245
Am J Epidemiol. 2010 Dec 15;172(12):1384-93
pubmed: 21051447
Eur J Cancer. 2008 Feb;44(3):465-71
pubmed: 18221867
Gut. 2007 Nov;56(11):1503-11
pubmed: 17337464
Eur J Cancer Prev. 2017 Jan;26(1):1-9
pubmed: 26886236
Int J Cancer. 2006 May 15;118(10):2628-31
pubmed: 16353151
Gastric Cancer. 2002;5(4):213-9
pubmed: 12491079
Cancer Causes Control. 2015 Dec;26(12):1825-34
pubmed: 26450604
Cancer Prev Res (Phila). 2011 Jun;4(6):840-50
pubmed: 21505180
Biosci Rep. 2017 May 11;37(3):null
pubmed: 28336766
Nat Rev Cancer. 2004 Aug;4(8):579-91
pubmed: 15286738
Oncol Rep. 2013 Oct;30(4):1622-30
pubmed: 23843035
Cancer Lett. 2002 Feb 25;176(2):129-35
pubmed: 11804739
Mol Cell Endocrinol. 2015 Feb 15;402:113-9
pubmed: 25578600
Eur J Cancer. 2008 Nov;44(16):2397-403
pubmed: 18755583
Cancer Causes Control. 2005 Apr;16(3):285-94
pubmed: 15947880
Ann Epidemiol. 2006 Dec;16(12):908-16
pubmed: 16843679
Epidemiology. 2011 Jan;22(1):118-26
pubmed: 21068668
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Br J Cancer. 2012 Jan 3;106(1):210-6
pubmed: 22127287
Ann Oncol. 2013 Mar;24(3):609-17
pubmed: 22898040
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1395-408
pubmed: 23697611
Diabetes. 2006 Apr;55(4):978-87
pubmed: 16567519
Nat Rev Gastroenterol Hepatol. 2011 Jun;8(6):340-7
pubmed: 21643038
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):352-8
pubmed: 18268119
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):20-38
pubmed: 22028402
Eur J Cancer. 2006 May;42(8):1151-8
pubmed: 16630714
J Clin Invest. 1983 Sep;72(3):1150-62
pubmed: 6350364
Int J Cancer. 2016 Jun 15;138(12):2837-45
pubmed: 26829904
Gut. 2012 Sep;61(9):1261-8
pubmed: 22174193
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Harinakshi Sanikini (H)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

David C Muller (DC)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Marisa Sophiea (M)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Sabina Rinaldi (S)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.

Eric J Duell (EJ)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.

Elisabete Weiderpass (E)

Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Genetic Epidemiology Group, Folkhälsan Research Center, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Kim Overvad (K)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Jytte Halkjaer (J)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Marie-Christine Boutron-Ruault (MC)

CESP, Faculté de Médecine, Université Paris-Sud, Villejuif, France.
Faculté de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Institut Gustave Roussy, Villejuif, France.

Franck Carbonnel (F)

CESP, Faculté de Médecine, Université Paris-Sud, Villejuif, France.
Faculté de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Institut Gustave Roussy, Villejuif, France.
Department of Gastroenterology, Bicêtre University Hospital, Assistance Publique des Hôpitaux de Paris, Le Kremlin-Bicêtre, France.

Iris Cervenka (I)

CESP, Faculté de Médecine, Université Paris-Sud, Villejuif, France.
Faculté de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Institut Gustave Roussy, Villejuif, France.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Georgia Martimianaki (G)

Hellenic Health Foundation, Athens, Greece.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

Valeria Pala (V)

Epidemiology and Prevention Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.

Amalia Mattiello (A)

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, "Civic - M. P. Arezzo" Hospital, ASP, Ragusa, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Guri Skeie (G)

Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.

Charlotta Rylander (C)

Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.

María-Dolores Chirlaque López (MD)

Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Health and Social Sciences, Murcia University, Murcia, Spain.

Maria-Jose Sánchez (MJ)

Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs, GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Eva Ardanaz (E)

Navarra Public Health Institute, Pamplona, Spain.
IdiSNA Navarra Institute for Health Research, Pamplona, Spain.
CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.

Sara Regnér (S)

Institution of Clinical Sciences Malmö, Skåne University Hospital, Lund University, Sweden.

Tanja Stocks (T)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Bas Bueno-de-Mesquita (B)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Roel C H Vermeulen (RCH)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Julius Centre for Public Health Sciences and Primary Care, Utrecht University Medical Centre, Utrecht, The Netherlands.

Dagfinn Aune (D)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Department of Nutrition, Bjørknes University College, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Tammy Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Nathalie Kliemann (N)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.

Neil Murphy (N)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.

Marc Chadeau-Hyam (M)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Marc J Gunter (MJ)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.

Amanda J Cross (AJ)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH